Stella Therapeutics' Grant

Stella Therapeutics raised a round of funding on September 17, 2013. Investors include Life Sciences Discovery Fund.

Stella Therapeutics, a privately held drug discovery company, is developing first-in-class small molecules that hold the promise of curing Glioblastoma Multiforme (GBM), the most common and deadliest …

Articles about Stella Therapeutics' Grant: